title: [Treatment of bronchial asthma in pregnancy].
abstract: The prevalence of bronchial asthma, similarly to the normal population, is also increasing among pregnant women. Asthma a chronic inflammatory disease of the airways, is one of the most common medical problems that can complicate pregnancy. The cornerstone of asthma management in pregnancy is to implement such treatment strategies that can maintain normal maternal pulmonary function and prevent fetal complications. The aim of the present article is to summarize the recent publications and guidelines on the safety and efficacy issues of asthma treatment during pregnancy.
authors.affiliation: Semmelweis Egyetem, Altalános Orvositudományi Kar, Pulmonológiai Klinika, Budapest.
authors.forename: Akos
authors.initials: A
authors.lastname: Somoskövi
authors.forename: Lilla
authors.initials: L
authors.lastname: Tamási
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Bártfai
authors.forename: Edina
authors.initials: E
authors.lastname: Tolnay
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy* / Q000503:physiopathology; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects; D013224:Status Asthmaticus / Q000188:drug therapy; D013806:Theophylline / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D018343:Receptors, Adrenergic, beta-2; D013806:Theophylline